| Diffuse Midline Glioma studied in …STUDIED_INderived10 of 129show all (up to 200) |
|---|
| → studied in | NCT01445288completed Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors · condition mapped ONTOLOGY_EXACT · 129 trials mapped (66 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04837547Phase 1 · active not recruiting PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy · condition mapped ONTOLOGY_EXACT · 129 trials mapped (66 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06838676Phase 2 · recruiting ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas · condition mapped ALIAS · 129 trials mapped (66 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05077735Phase 2 · active not recruiting Stereotactic Biopsy Split-Course Radiation Therapy in Diffuse Midline Glioma, SPORT-DMG Trial · condition mapped ONTOLOGY_EXACT · 129 trials mapped (66 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06357377Phase 1 · recruiting A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors · condition mapped ONTOLOGY_EXACT · 129 trials mapped (66 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07389278Phase 1/Phase 2 · not yet recruiting Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG) · condition mapped ONTOLOGY_EXACT · 129 trials mapped (66 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04870944Phase 1/Phase 2 · recruiting CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma · condition mapped ONTOLOGY_EXACT · 129 trials mapped (66 active) | — | — | Diffuse Midline Glioma, H3 K27-Altered | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06639607Phase 1/Phase 2 · suspended PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma · condition mapped ONTOLOGY_EXACT · 129 trials mapped (66 active) | — | — | Diffuse Midline Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06946680Phase 1 · not yet recruiting IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG) · condition mapped ONTOLOGY_EXACT · 129 trials mapped (66 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07644312Phase 2 · not yet recruiting Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPG · condition mapped ONTOLOGY_EXACT · 129 trials mapped (66 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |